The stated Phase I activities and expected deliverables of this SBIR Contract include: 1) Development of proof-of-concept technologies that reliably generate anti-peptide capture reagents that can immunoprecipitate the target peptides;2) Demonstrate that the capture reagents developed can reproducibly immunoprecipitate the target peptides;3) Work with the CPTC community, private and public sector to identify minimum characterization criteria for validation of the assays;4) Generate affinity reagents to at least ten proteotypic peptides and demonstrate high affinity, specificity and immunoprecipitation performance;5) Make available to NCI sufficient reagents to perform 10 test runs for each of the ten peptides for independent evaluation;6) Present findings to an NCI CPTC Evaluation Panel demonstrating how the capture reagents have improved cost effectiveness and throughput capabilities in production.

Agency
National Institute of Health (NIH)
Type
Small Business Innovation Research – Phase I (N43)
Project #
261201300053C-0-0-1
Application #
8762565
Study Section
Project Start
2013-09-13
Project End
2014-06-12
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$199,565
Indirect Cost
Name
Base Pair Biotechnologies, Inc.
Department
Type
DUNS #
078474555
City
Houston
State
TX
Country
United States
Zip Code
77054